Canopy Growth Corporation
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Luc Mongeau
- Full Time Employees
- 1,029
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1 Hershey Drive Smiths Falls ON Canada K7A 0A8
- IPO Date
- Apr 7, 2014
- CIK
- 0001737927
- Website
- canopygrowth.com
- Similar Companies
- Business
- Canopy Growth Corporation is a leading global diversified cannabis company engaged in the cultivation, production, and sale of cannabis and cannabinoid-based products. The company offers an extensive portfolio including dried cannabis flower, pre-rolls, oils, softgels, edibles, and beverages, catering to both medical and recreational markets. Its core brands include Tweed, 7ACRES, DOJA, Deep Space, Claybourne, and medical cannabis through its subsidiary Storz & Bickel GmbH & Co. KG, which specializes in cannabis vaporization devices. Canopy operates large-scale GMP-certified indoor and greenhouse cultivation facilities primarily in Canada, with significant operations in the United States, Germany, the United Kingdom, and emerging markets in Australia, Denmark, Peru, and Brazil. Founded in 2013 and headquartered in Smiths Falls, Ontario, Canada, the company focuses on rigorous quality assurance, genetic research, and innovative product development. In the past two years, Canopy Growth has strategically sharpened its operational focus by divesting non-cannabis businesses and adopting an asset-light, brand-driven model to reduce complexity and cost structure. The company has advanced its product innovation with launches such as the advanced all-in-one vape devices featuring CCELL technology under the Tweed and 7ACRES brands to capture demand in premium vaporization formats. Financially, Canopy has improved stability by reducing costs, cash burn, and debt, while targeting positive adjusted EBITDA. It has made significant operational shifts including reallocating its Kelowna DOJA operations towards specialized medical cannabis cultivation and expanding into the wellness market with hemp-derived products under initiatives like Wana Wellness. Canopy also maintains a strategic option to acquire Acreage Holdings in the US, pending federal legalization, positioning it for accelerated entry into the American cannabis market. Canopy Growth's comprehensive range of cannabis products, global geographic footprint, and recent emphasis on operational efficiency and innovation underpin its role as a market leader in the cannabis industry. The company continues to focus on premium and mainstream cannabis products designed to improve lives while pursuing growth through strategic partnerships, focused market expansion, and advanced product offerings. It employs approximately 960 people and reported revenue growth and margin improvements in its Canadian cannabis segment amid ongoing cost reduction efforts. Its headquarters remain at 1 Hershey Drive, Smiths Falls, Ontario.
Canopy Growth Just Made a Big Acquisition: Game-Changer -- or Another Misstep?
3 Canadian Marijuana Stocks That Could Help You Make Money
Canopy Growth Corporation (CGC) Stock Dips While Market Gains: Key Facts
Canopy Growth Still Looks Broken -- But These 3 Numbers Suggest a Turnaround May Be Starting
The Market Overreacted to the DEA's Marijuana Rescheduling -- Here's What It Means for Canopy Growth Stock Now
Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup, Marking First International Release following Acquisition
Canopy Growth Relaunches Tweed Brand in Germany with New MTL Cannabis Strain Lineup, Marking First International Release following Acquisition
Top Canadian Marijuana Stocks for Your Watchlist Before June 2026
Canopy Growth Corporation (CGC) Exceeds Market Returns: Some Facts to Consider
Canopy Growth Is Restating Two Years of Financials Before June 15 Earnings -- Here's What CGC Investors Need to Know Right Now
Should You Buy CGC Stock After Marijuana Reclassification?
Canopy Growth's Stock Just Dropped -- Here's Why I'm Still Not Buying
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today
Canopy Growth Provides Update on Financial Reporting and Announces Fourth Quarter and Fiscal Year 2026 Financial Results to be Presented on June 15, 2026
Canadian Marijuana Stocks Showing Strong Momentum in May
Canopy Growth Is One of the Market's Most Polarizing Stocks: 3 Scenarios for the Next 12 Months
Canopy Growth Corporation (CGC) Registers a Bigger Fall Than the Market: Important Facts to Note
Canopy Growth and Spectrum Therapeutics Expand Medical Portfolio with New 30 and 90-Pack Softgels and Enhanced Dosing Options
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know